HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kiely, J L Articles by McNicholas, W T Search for Related Content PubMed PubMed Citation Articles by Kiely, J L Articles by McNicholas, W T

Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis

¹ Department of Respiratory Medicine and the Respiratory Sleep Disorders Unit, St Vincent’s University Hospital, Dublin, Ireland
² Department of Human Anatomy and Physiology, University College, Dublin, Ireland

Correspondence to:
Correspondence to:
Professor W T McNicholas
Department of Respiratory Medicine, St Vincent’s University Hospital, Elm Park, Dublin 4, Ireland; walter.mcnicholas{at}ucd.ie

ABSTRACT
Background: Increased nasal airflow resistance (NAR) may contribute to the pathophysiology of obstructive sleep apnoea syndrome (OSAS) but studies investigating the effects of relieving nasal obstruction in OSAS have produced differing results. There are no reports of intranasal corticosteroid therapy in adult OSAS patients with reversible nasal obstruction.

Methods: We evaluated an intranasal corticosteroid, fluticasone propionate, in 24 consecutive snorers with associated rhinitis using a randomised, placebo controlled, crossover design. Patients underwent polysomnography, snoring noise, and NAR measurements at baseline and after each 4 week treatment period.

Results: Twenty three patients completed the protocol and were divided into an apnoeic group (group A; 13 patients) and a non-apnoeic snoring group (group S; 10 patients) based on an apnoea-hypopnoea frequency (AHI) of 10/h or <10/h. AHI was significantly lower following treatment with fluticasone than with placebo in the total population (median (quartile range) 11.9 (22.6) v 20 (26.3); p<0.05) and in group A (23.3 (21.3) v 30.3 (31.9); p<0.05). Median (95% confidence interval) within subject differences for AHI were -3.2 (-17.7 to -0.2) in the total population and -6.5 (-29.5 to 1.8) in group A. NAR was also lower on fluticasone (2.74 (1.21) v 3.27 (1.38), p<0.01), within subject difference being -0.45 (95% CI -0.87 to -0.21). The changes in AHI and NAR in group A were significantly correlated (r = 0.56; p<0.05). Snoring noise and sleep quality were unchanged but daily diary records indicated subjective improvements in nasal congestion and daytime alertness with fluticasone (p<0.02).

Conclusions: Intranasal fluticasone is of benefit to some patients with OSAS and rhinitis. The data suggest that this form of nasal obstruction may contribute to the pathophysiology of OSAS.

Keywords: intranasal corticosteroids; sleep apnoea; rhinitis

This article has been cited by other articles:

				G. Jayaraman, H. Sharafkhaneh, M. Hirshkowitz, and A. Sharafkhaneh Review: Pharmacotherapy of obstructive sleep apnea Therapeutic Advances in Respiratory Disease, December 1, 2008; 2(6): 375 - 386. [Abstract] [PDF]

				W. T. McNicholas The nose and OSA: variable nasal obstruction may be more important in pathophysiology than fixed obstruction Eur. Respir. J., July 1, 2008; 32(1): 3 - 8. [Full Text] [PDF]

				I. Koutsourelakis, G. Georgoulopoulos, E. Perraki, E. Vagiakis, C. Roussos, and S. G. Zakynthinos Randomised trial of nasal surgery for fixed nasal obstruction in obstructive sleep apnoea Eur. Respir. J., January 1, 2008; 31(1): 110 - 117. [Abstract] [Full Text] [PDF]

				M. Kohler, K. E. Bloch, and J. R. Stradling The role of the nose in the pathogenesis of obstructive sleep apnoea and snoring Eur. Respir. J., December 1, 2007; 30(6): 1208 - 1215. [Abstract] [Full Text] [PDF]

				P. Virkkula, A. Bachour, M. Hytonen, T. Salmi, H. Malmberg, K. Hurmerinta, and P. Maasilta Snoring Is Not Relieved by Nasal Surgery Despite Improvement in Nasal Resistance Chest, January 1, 2006; 129(1): 81 - 87. [Abstract] [Full Text] [PDF]

				C. M. Ryan and T. D. Bradley Pathogenesis of obstructive sleep apnea J Appl Physiol, December 1, 2005; 99(6): 2440 - 2450. [Abstract] [Full Text] [PDF]

				A. Bachour and P. Maasilta Mouth Breathing Compromises Adherence to Nasal Continuous Positive Airway Pressure Therapy Chest, October 1, 2004; 126(4): 1248 - 1254. [Abstract] [Full Text] [PDF]

				Other articles noted Evid. Based Med., March 1, 2004; 9(2): 63 - 64. [Full Text] [PDF]